Survey of Somatic Mutations in Tuberous Sclerosis Complex (TSC) Hamartomas Suggests Different Genetic Mechanisms for Pathogenesis of TSC Lesions

This publication has 52 references indexed in Scilit:

• NF1 Tumor Suppressor Gene Function: Narrowing the GAP
  Published by Elsevier ,2001
• Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease
  Human Molecular Genetics, 2000
• Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background
  Journal of Clinical Investigation, 1999
• Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systems
  Proceedings of the National Academy of Sciences, 1999
• Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation
  The EMBO Journal, 1998
• Loss of heterozygosity in tuberous sclerosis hamartomas.
  Journal of Medical Genetics, 1996
• Localization of Tuberous Sclerosis 2 mRNA and its Protein Product Tuberin in Normal Human Brain and in Cerebral Lesions of Patients with Tuberous Sclerosis
  Brain Pathology, 1996
• Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat
  Molecular Carcinogenesis, 1995
• Alternative Splicing of the Tuberous Sclerosis 2 (TSC2) Gene in Human and Mouse Tissues
  Genomics, 1995
• Identification and characterization of the tuberous sclerosis gene on chromosome 16
  Cell, 1993